Cargando…

Poxvirus tropism

Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population. Even today, we are still mostly igno...

Descripción completa

Detalles Bibliográficos
Autor principal: McFadden, Grant
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382915/
https://www.ncbi.nlm.nih.gov/pubmed/15738948
http://dx.doi.org/10.1038/nrmicro1099
_version_ 1782364645502222336
author McFadden, Grant
author_facet McFadden, Grant
author_sort McFadden, Grant
collection PubMed
description Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population. Even today, we are still mostly ignorant about why most poxvirus infections of vertebrate hosts show strict species specificity, or how zoonotic poxvirus infections occur when poxviruses occasionally leap into novel host species. Poxvirus tropism at the cellular level seems to be regulated by intracellular events downstream of virus binding and entry, rather than at the level of specific host receptors as is the case for many other viruses. This review summarizes our current understanding of poxvirus tropism and host range, and discusses the prospects of exploiting host-restricted poxvirus vectors for vaccines, gene therapy or tissue-targeted oncolytic viral therapies for the treatment of human cancers.
format Online
Article
Text
id pubmed-4382915
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-43829152015-04-02 Poxvirus tropism McFadden, Grant Nat Rev Microbiol Article Despite the success of the WHO-led smallpox eradication programme a quarter of a century ago, there remains considerable fear that variola virus, or other related pathogenic poxviruses such as monkeypox, could re-emerge and spread disease in the human population. Even today, we are still mostly ignorant about why most poxvirus infections of vertebrate hosts show strict species specificity, or how zoonotic poxvirus infections occur when poxviruses occasionally leap into novel host species. Poxvirus tropism at the cellular level seems to be regulated by intracellular events downstream of virus binding and entry, rather than at the level of specific host receptors as is the case for many other viruses. This review summarizes our current understanding of poxvirus tropism and host range, and discusses the prospects of exploiting host-restricted poxvirus vectors for vaccines, gene therapy or tissue-targeted oncolytic viral therapies for the treatment of human cancers. Nature Publishing Group UK 2005 /pmc/articles/PMC4382915/ /pubmed/15738948 http://dx.doi.org/10.1038/nrmicro1099 Text en © Nature Publishing Group 2005 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
McFadden, Grant
Poxvirus tropism
title Poxvirus tropism
title_full Poxvirus tropism
title_fullStr Poxvirus tropism
title_full_unstemmed Poxvirus tropism
title_short Poxvirus tropism
title_sort poxvirus tropism
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4382915/
https://www.ncbi.nlm.nih.gov/pubmed/15738948
http://dx.doi.org/10.1038/nrmicro1099
work_keys_str_mv AT mcfaddengrant poxvirustropism